Methods for the economic evaluation of health care programmes MF Drummond, MJ Sculpher, K Claxton, GL Stoddart, GW Torrance Oxford university press, 2015 | 23189 | 2015 |
Decision modelling for health economic evaluation A Briggs, M Sculpher, K Claxton Oup Oxford, 2006 | 3927 | 2006 |
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre … GJ Peek, M Mugford, R Tiruvoipati, A Wilson, E Allen, MM Thalanany, ... The Lancet 374 (9698), 1351-1363, 2009 | 3475 | 2009 |
Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine GD Sanders, PJ Neumann, A Basu, DW Brock, D Feeny, M Krahn, ... Jama 316 (10), 1093-1103, 2016 | 2785 | 2016 |
Endovascular versus open repair of abdominal aortic aneurysm United Kingdom EVAR Trial Investigators New England Journal of Medicine 362 (20), 1863-1871, 2010 | 1690 | 2010 |
Representing uncertainty: the role of cost‐effectiveness acceptability curves E Fenwick, K Claxton, M Sculpher Health economics 10 (8), 779-787, 2001 | 1258 | 2001 |
An introduction to Markov modelling for economic evaluation A Briggs, M Sculpher Pharmacoeconomics 13 (4), 397-409, 1998 | 1248 | 1998 |
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. K Claxton, S Martin, M Soares, N Rice, E Spackman, S Hinde, N Devlin, ... Health Technology Assessment (Winchester, England) 19 (14), 1, 2015 | 1055 | 2015 |
Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility A Manca, N Hawkins, MJ Sculpher Health economics 14 (5), 487-496, 2005 | 1031 | 2005 |
Country-level cost-effectiveness thresholds: initial estimates and the need for further research B Woods, P Revill, M Sculpher, K Claxton Value in Health 19 (8), 929-935, 2016 | 857 | 2016 |
Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Z Philips, L Ginnelly, M Sculpher, K Claxton, S Golder, R Riemsma, ... Health technology assessment (Winchester, England) 8 (36), iii-iv, ix, 2004 | 834 | 2004 |
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6 AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ... Medical decision making 32 (5), 722-732, 2012 | 780 | 2012 |
Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ... Value in Health 15 (6), 835-842, 2012 | 776 | 2012 |
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis A Briggs, M Sculpher, M Buxton Health economics 3 (2), 95-104, 1994 | 664 | 1994 |
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised … CE Coles, CL Griffin, AM Kirby, J Titley, RK Agrawal, A Alhasso, ... The Lancet 390 (10099), 1048-1060, 2017 | 615 | 2017 |
Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report M Drummond, M Barbieri, J Cook, HA Glick, J Lis, F Malik, SD Reed, ... Value in health 12 (4), 409-418, 2009 | 608 | 2009 |
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment Z Philips, L Bojke, M Sculpher, K Claxton, S Golder Pharmacoeconomics 24, 355-371, 2006 | 593 | 2006 |
A rational framework for decision making by the National Institute for Clinical Excellence (NICE) K Claxton, M Sculpher, M Drummond The Lancet 360 (9334), 711-715, 2002 | 572 | 2002 |
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra K Claxton, M Sculpher, C McCabe, A Briggs, R Akehurst, M Buxton, ... Health economics 14 (4), 339-347, 2005 | 561 | 2005 |
Whither trial‐based economic evaluation for health care decision making? MJ Sculpher, K Claxton, M Drummond, C McCabe Health economics 15 (7), 677-687, 2006 | 510 | 2006 |